Huons Global Completes Phase 1 Clinical Trial of HU-045 for Glabellar Wrinkle Improvement
[Asia Economy Reporter Minji Lee] Huons Global announced on the 10th that the improvement effect on glabellar wrinkles was confirmed in the domestic Phase 1 clinical trial evaluating the safety of HU-045 injection for adults requiring improvement of severe glabellar wrinkles.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Seongdong Police Station Chief Placed on Standby for Misuse of Official Vehicle... National Police Agency Launches Audit
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The company stated, "Based on the results of the Phase 1 study, we plan to apply to the Ministry of Food and Drug Safety for the next phase clinical trial," and added, "We expect to generate economic benefits through domestic approval."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.